Twist Bioscience CorporationTWSTNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
4.22
↓ 83% below average
Average (9y)
24.61
Historical baseline
Range
High:108.20
Low:3.92
CAGR
-30.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2025 | 4.22 | -46.7% |
| 2024 | 7.92 | +102.3% |
| 2023 | 3.92 | -50.6% |
| 2022 | 7.93 | -77.9% |
| 2021 | 35.96 | +11.0% |
| 2020 | 32.40 | +185.7% |
| 2019 | 11.34 | -4.4% |
| 2018 | 11.86 | -47.0% |
| 2017 | 22.37 | -79.3% |
| 2016 | 108.20 | - |